Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Insiderslab.com; Insiders.hk
HONG KONG, Oct. 16, 2013 /PRNewswire/ -- U.S. market investors can reveal the performance of company insiders from the insider trading reports. Today's reports will cover the following stocks: Opko Health (NYSE:OPK), ACADIA Pharmaceuticals (NASDAQ:ACAD), Synaptics (NASDAQ:SYNA), Intel (NASDAQ:INTC), Charles Schwab (NYSE:SCHW), and Molycorp (NYSE:MCP).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Opko Health Inc. (NYSE:OPK): By the end of last trading session, the shares of Opko Health (NYSE:OPK) soared 12.56% (or US$1.37) to US$12.28 with 19.14 million shares exchanged hands, compared to daily average volume of 4.73 million. Within the last trading session, the share hit a new 52-week high of US$12.84. Insiderslab.com found company CEO & Chairman Frost Phillip MD Et Al. purchased his shares at the price of US$10.03 on October 11. Investors may want to find out how Opko Health insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for OPK here.
Read Full Report: http://www.insiderslab.com/PR3/101613A/OPK/OpkoHealth.pdf
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD): By the end of last trading session, ACADIA Pharmaceuticals (NASDAQ:ACAD) shares lost 1.62% to US$23.13 with about 4.84 million shares exchanged hands for the session, compared to its average volume of 3.08 million shares. Insiderslab.com found company Director Laura Brege sold her shares at the price of US$21.63 on October 10. Investors may want to find out how ACADIA Pharmaceuticals insiders like CEOs, CFOs and Directors are thinking about the future of the company.
Read Full Report: http://www.insiderslab.com/PR3/101613A/ACAD/ACADIA.pdf
Synaptics, Incorporated (NASDAQ:SYNA): By the end of last trading session, Synaptics (NASDAQ:SYNA) shares jumped 5.69% to US$52.16 with about 3.44 million shares exchanged hands for the session, compared to its average volume of 0.90 million shares. Insiderslab.com found company Director Russell J. Knittel sold his shares at the price of US$48.97 for about US$6.42 million on October 10. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Synaptics are starting to sell more company shares. See insider trade report for SYNA here.
Read Full Report: http://www.insiderslab.com/PR3/101613A/SYNA/Synaptics.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Intel Corporation (NASDAQ:INTC):
Read Full Report: http://www.insiderslab.com/PR3/101613A/INTC/Intel.pdf
Charles Schwab Corp. (NYSE:SCHW):
Read Full Report: http://www.insiderslab.com/PR3/101613A/SCHW/CharlesSchwab.pdf
Molycorp Inc. (NYSE:MCP):
Read Full Report: http://www.insiderslab.com/PR3/101613A/MCP/Molycorp.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
©2012 PR Newswire. All Rights Reserved.